Company Description
Community Health Systems, Inc. engages in the management and operations of hospitals. It operates general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services. The company was founded in March 1985 and is headquartered in Franklin, TN.
Valuation
P/E Current
14.00
P/E Ratio (with extraordinary items)
14.30
P/E Ratio (without extraordinary items)
12.21
Price to Sales Ratio
0.05
Price to Cash Flow Ratio
1.87
Enterprise Value to EBITDA
10.25
Enterprise Value to Sales
1.06
Total Debt to Enterprise Value
0.92
Efficiency
Revenue/Employee
185,015.00
Income Per Employee
697.00
Receivables Turnover
5.66
Total Asset Turnover
0.82
Liquidity
Current Ratio
1.41
Quick Ratio
1.25
Cash Ratio
0.05
Profitability
Gross Margin
5.96
Operating Margin
5.96
Pretax Margin
2.86
Net Margin
0.38
Return on Assets
0.31
Return on Total Capital
6.15
Return on Invested Capital
0.42
Capital Structure
Total Debt to Total Capital
112.40
Total Debt to Total Assets
84.45
Long-Term Debt to Total Capital
110.87
Officers and Executives
Name | Age | Officer Since | Title |
---|---|---|---|
Mr. Wayne T. Smith | 74 | 1997 | Chairman & Chief Executive Officer |
Mr. Kevin J. Hammons | 55 | 1997 | Treasurer, Chief Accounting Officer & Senior VP |
Mr. Tim L. Hingtgen | 52 | 2008 | President, Chief Executive Officer, COO & Director |
Dr. Lynn T. Simon | 61 | 2010 | Chief Quality Officer & Senior Vice President |
Mr. Manish Shah | - | 2013 | Chief Information Officer & Senior Vice President |
Insider Actions
03/01/2023 |
Wayne T. Smith Director |
30,050 | Gift at $0 per share. | 0 |
03/01/2023 |
Wayne T. Smith Director |
126,905 | Derivative/Non-derivative trans. at $6.15 per share. | 780,465 |
03/01/2023 |
Tim L. Hingtgen CEO; Director |
95,096 | Derivative/Non-derivative trans. at $6.15 per share. | 584,840 |
03/01/2023 |
Kevin J. Hammons President and CFO |
63,290 | Derivative/Non-derivative trans. at $6.15 per share. | 389,233 |
03/01/2023 |
Lynn T. Simon President and CMO |
34,596 | Derivative/Non-derivative trans. at $6.15 per share. | 212,765 |
03/01/2023 |
Justin D. Pitt EVP and General Counsel |
1,484 | Derivative/Non-derivative trans. at $6.15 per share. | 9,126 |
03/01/2023 |
Justin D. Pitt EVP and General Counsel |
15,319 | Derivative/Non-derivative trans. at $6.15 per share. | 94,211 |
03/01/2023 |
Jason K. Johnson SVP & CAO |
12,790 | Derivative/Non-derivative trans. at $6.15 per share. | 78,658 |
03/01/2023 |
Kevin A Stockton Regional President |
15,181 | Derivative/Non-derivative trans. at $6.15 per share. | 93,363 |
03/01/2023 |
Chad A Campbell Regional President |
13,119 | Derivative/Non-derivative trans. at $6.15 per share. | 80,681 |
03/01/2023 |
Mark B. Medley Regional President |
13,119 | Derivative/Non-derivative trans. at $6.15 per share. | 80,681 |
03/01/2023 |
Wayne T. Smith Director |
225,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
Tim L. Hingtgen CEO; Director |
150,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
Kevin J. Hammons President and CFO |
95,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
Lynn T. Simon President and CMO |
52,500 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
Jim S. Ely Director |
5,894 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
John A. Clerico Director |
5,894 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
John A. Clerico Director |
6,432 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
John A. Clerico Director |
11,494 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
Justin D. Pitt EVP and General Counsel |
20,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
John A. Fry Director |
5,894 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
John A. Fry Director |
6,432 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
John A. Fry Director |
11,494 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
Michael Dinkins Director |
5,894 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
Michael Dinkins Director |
6,432 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
Michael Dinkins Director |
11,494 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
Jason K. Johnson SVP & CAO |
15,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
Hubert James Williams Director |
5,894 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
Kevin A Stockton Regional President |
15,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
Chad A Campbell Regional President |
15,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
Mark B. Medley Regional President |
15,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
Elizabeth T. Hirsch Director |
5,894 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
Elizabeth T. Hirsch Director |
6,432 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2023 |
Tim L. Hingtgen CEO; Director |
200,000 | Award at $0 per share. | 0 |
03/01/2023 |
Kevin J. Hammons President and CFO |
90,000 | Award at $0 per share. | 0 |
03/01/2023 |
Lynn T. Simon President and CMO |
40,000 | Award at $0 per share. | 0 |
03/01/2023 |
Justin D. Pitt EVP and General Counsel |
5,000 | Award at $0 per share. | 0 |
03/01/2023 |
Justin D. Pitt EVP and General Counsel |
30,000 | Award at $0 per share. | 0 |
03/01/2023 |
Jason K. Johnson SVP & CAO |
30,000 | Award at $0 per share. | 0 |
03/01/2023 |
Kevin A Stockton Regional President |
25,000 | Award at $0 per share. | 0 |
03/01/2023 |
Chad A Campbell Regional President |
25,000 | Award at $0 per share. | 0 |
03/01/2023 |
Mark B. Medley Regional President |
25,000 | Award at $0 per share. | 0 |
03/01/2023 |
Austen D Mason Regional President |
25,000 | Award at $0 per share. | 0 |
12/22/2022 |
Wayne T. Smith Director |
19,340 | Gift at $0 per share. | 0 |
08/02/2022 |
Wayne T. Smith Director |
800,000 | Acquisition at $2.94 per share. | 2,352,000 |
08/01/2022 |
Wayne T. Smith Director |
200,000 | Acquisition at $3 per share. | 600,000 |
06/30/2022 |
K. Ranga Rama Krishnan Director |
37,957 | Derivative/Non-derivative trans. at $0 per share. | 0 |
06/02/2022 |
Jim S. Ely Director |
10,000 | Acquisition at $5 per share. | 50,000 |
06/01/2022 |
Jim S. Ely Director |
30,000 | Acquisition at $5.09 per share. | 152,700 |
06/01/2022 |
Mark B. Medley Regional President |
1,574 | Derivative/Non-derivative trans. at $5 per share. | 7,870 |
05/31/2022 |
Jim S. Ely Director |
10,000 | Acquisition at $5.12 per share. | 51,200 |
03/02/2022 |
Justin D. Pitt EVP and General Counsel |
17,087 | Derivative/Non-derivative trans. at $10.18 per share. | 173,945 |
03/01/2022 |
Wayne T. Smith Director |
160,845 | Derivative/Non-derivative trans. at $10.18 per share. | 1,637,402 |
03/01/2022 |
Tim L. Hingtgen CEO; Director |
118,872 | Derivative/Non-derivative trans. at $10.18 per share. | 1,210,116 |
03/01/2022 |
Kevin J. Hammons President and CFO |
32,596 | Derivative/Non-derivative trans. at $10.18 per share. | 331,827 |
03/01/2022 |
Lynn T. Simon President and CMO |
53,453 | Derivative/Non-derivative trans. at $10.18 per share. | 544,151 |
03/01/2022 |
Lynn T. Simon President and CMO |
53,543 | Derivative/Non-derivative trans. at $10.18 per share. | 545,067 |
03/01/2022 |
Justin D. Pitt EVP and General Counsel |
1,385 | Derivative/Non-derivative trans. at $10.18 per share. | 14,099 |
03/01/2022 |
Jason K. Johnson SVP & CAO |
5,497 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2022 |
Kevin A Stockton Regional President |
6,350 | Derivative/Non-derivative trans. at $10.18 per share. | 64,643 |
03/01/2022 |
Chad A Campbell Regional President |
5,510 | Derivative/Non-derivative trans. at $10.18 per share. | 56,091 |
03/01/2022 |
Mark B. Medley Regional President |
3,936 | Derivative/Non-derivative trans. at $10.18 per share. | 40,068 |
03/01/2022 |
Wayne T. Smith Director |
90,000 | Award at $0 per share. | 0 |
03/01/2022 |
Tim L. Hingtgen CEO; Director |
100,000 | Award at $0 per share. | 0 |
03/01/2022 |
Kevin J. Hammons President and CFO |
75,000 | Award at $0 per share. | 0 |
03/01/2022 |
Lynn T. Simon President and CMO |
40,000 | Award at $0 per share. | 0 |
03/01/2022 |
Justin D. Pitt EVP and General Counsel |
5,000 | Award at $0 per share. | 0 |
03/01/2022 |
Justin D. Pitt EVP and General Counsel |
30,000 | Award at $0 per share. | 0 |
03/01/2022 |
Jason K. Johnson SVP & CAO |
25,000 | Award at $0 per share. | 0 |
03/01/2022 |
Kevin A Stockton Regional President |
25,000 | Award at $0 per share. | 0 |
03/01/2022 |
Chad A Campbell Regional President |
25,000 | Award at $0 per share. | 0 |
03/01/2022 |
Mark B. Medley Regional President |
25,000 | Award at $0 per share. | 0 |
03/01/2022 |
Austen D Mason Regional President |
25,000 | Award at $0 per share. | 0 |
03/01/2022 |
Wayne T. Smith Director |
315,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2022 |
Tim L. Hingtgen CEO; Director |
225,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2022 |
Kevin J. Hammons President and CFO |
36,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2022 |
Lynn T. Simon President and CMO |
105,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2022 |
Jim S. Ely Director |
11,356 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2022 |
John A. Clerico Director |
6,432 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2022 |
John A. Clerico Director |
11,495 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2022 |
John A. Clerico Director |
11,356 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2022 |
Justin D. Pitt EVP and General Counsel |
30,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2022 |
John A. Fry Director |
6,432 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2022 |
John A. Fry Director |
11,495 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2022 |
John A. Fry Director |
11,356 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2022 |
Michael Dinkins Director |
6,432 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2022 |
Michael Dinkins Director |
11,495 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2022 |
Michael Dinkins Director |
11,356 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2022 |
K. Ranga Rama Krishnan Director |
11,356 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2022 |
Hubert James Williams Director |
11,356 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2022 |
William Norris Jennings Director |
11,356 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2022 |
Elizabeth T. Hirsch Director |
6,432 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/01/2022 |
Elizabeth T. Hirsch Director |
11,356 | Derivative/Non-derivative trans. at $0 per share. | 0 |
MarketWatch News on CYH
-
Universal Health Services Inc. Cl B stock falls Thursday, underperforms market
- MarketWatch Automation
-
HCA Healthcare Inc. stock falls Thursday, underperforms market
- MarketWatch Automation
-
Universal Health Services Inc. Cl B stock underperforms Wednesday when compared to competitors
- MarketWatch Automation
-
HCA Healthcare Inc. stock outperforms competitors despite losses on the day
- MarketWatch Automation
-
Universal Health Services Inc. Cl B stock outperforms competitors on strong trading day
- MarketWatch Automation
-
HCA Healthcare Inc. stock rises Tuesday, still underperforms market
- MarketWatch Automation
-
Universal Health Services Inc. Cl B stock outperforms competitors on strong trading day
- MarketWatch Automation
-
HCA Healthcare Inc. stock rises Monday, outperforms market
- MarketWatch Automation
-
Universal Health Services Inc. Cl B stock falls Friday, underperforms market
- MarketWatch Automation
-
HCA Healthcare Inc. stock falls Friday, underperforms market
- MarketWatch Automation
-
Universal Health Services Inc. Cl B stock rises Thursday, outperforms market
- MarketWatch Automation
-
HCA Healthcare Inc. stock rises Thursday, outperforms market
- MarketWatch Automation
-
Universal Health Services Inc. Cl B stock outperforms competitors on strong trading day
- MarketWatch Automation
-
HCA Healthcare Inc. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
Universal Health Services Inc. Cl B stock rises Tuesday, still underperforms market
- MarketWatch Automation
-
HCA Healthcare Inc. stock rises Tuesday, still underperforms market
- MarketWatch Automation
-
Universal Health Services Inc. Cl B stock underperforms Monday when compared to competitors
- MarketWatch Automation
-
HCA Healthcare Inc. stock rises Monday, outperforms market
- MarketWatch Automation
-
Universal Health Services Inc. Cl B stock outperforms competitors despite losses on the day
- MarketWatch Automation
-
HCA Healthcare Inc. stock falls Friday, underperforms market
- MarketWatch Automation
- Loading more headlines...
Other News on CYH
-
Community Health Systems Avoids Part of Quorum Bankruptcy Lawsuit
- The Wall Street Journal Interactive Edition
-
Small-Cap Stocks Shine in Market Reversal
- The Wall Street Journal Interactive Edition
-
10-K: COMMUNITY HEALTH SYSTEMS INC
- Edgar Online - (EDG = 10Q, 10K)
-
U.S. Physical Therapy: Not The Most Comfortable Prospect
- Seeking Alpha
-
Raising Money on Wall Street Hasn’t Been This Hard in a Decade
- The Wall Street Journal Interactive Edition
-
10-Q: COMMUNITY HEALTH SYSTEMS INC
- Edgar Online - (EDG = 10Q, 10K)
-
YMAB and FDMT among mid-day movers
- Seeking Alpha
-
Community Health Systems Q3 2022 Earnings Preview
- Seeking Alpha
-
Notable earnings after Wednesday's close
- Seeking Alpha
- Loading more headlines...